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ABSTRACT
Objective To examine symptom severity and duration 
at time of referral to secondary care for heavy menstrual 
bleeding (HMB) by socioeconomic deprivation, age and 
ethnicity
Design Cohort analysis of data from the National HMB 
Audit linked to Hospital Episode Statistics data.
Setting English and Welsh National Health Services 
(secondary care): February 2011 to January 2012.
Participants 15 325 women aged 18–60 years in 
England and Wales who had a new referral for HMB to a 
gynaecology outpatient department
Methods Multivariable linear regression to calculate 
adjusted differences in mean symptom severity and quality 
of life scores at first outpatient visit. Multivariable logistic 
regression to calculate adjusted ORs. Adjustment for body 
mass index, parity and comorbidities.
Primary outcome measures Mean symptom severity 
score (0=best, 100=worst), mean condition-specific 
quality of life score (0=worst, 100=best) and symptom 
duration (≥1 year).
Results Women were on average 42 years old and 12% 
reported minority ethnic backgrounds. Mean symptom 
severity and condition-specific quality of life scores were 
61.8 and 34.7. Almost three-quarters of women (74%) 
reported having had symptoms for ≥1 year. Women from 
more deprived areas had more severe symptoms at their 
first outpatient visit (difference −6.1; 95% CI−7.2 to −4.9, 
between least and most deprived quintiles) and worse 
condition-specific quality of life (difference 6.3; 95% CI 5.1 
to 7.5). Symptom severity declined with age while quality 
of life improved.
Conclusions Women living in more deprived areas 
reported more severe HMB symptoms and poorer quality 
of life at the start of treatment in secondary care. Providers 
should examine referral practices to explore if these 
differences reflect women’s health-seeking behaviour or 
how providers decide whether or not to refer.
InTRODuCTIOn 
Heavy menstrual bleeding (HMB) is a 
common condition that affects one in four 
women of reproductive age. In England and 
Wales, an estimated 50 000 women with HMB 
are referred from primary care to secondary 
care gynaecology services provided by the 
National Health Service (NHS) every year.1 
Menstrual disorders account for approxi-
mately 20% of referrals to specialist gynae-
cology services2 and studies have found 
significant regional variations in use of 
surgical treatment within England.3 
Women with HMB have significantly worse 
quality of life (QoL) than women with normal 
menstrual bleeding loss, in terms of their 
physical and mental health, as well as their 
Strengths and limitations of this study
 ► This study is the first to examine heavy menstrual 
bleeding (HMB) symptom severity and duration at 
time of referral to secondary care.
 ► The inclusion of patient-reported symptom severity 
and quality of life addresses a knowledge gap about 
how women feel about their HMB.
 ► As the data were collected by a national audit in 
England and Wales, the sample is relatively large, 
allowing comparisons between ethnic groups.
 ► Even though the sample size is large, the National 
HMB Audit recruited approximately 30% of eligible 
women. However, the characteristics of the women 
recruited were broadly representative of the UK 
population in terms of ethnicity and age.
 ► Linking audit data to administrative hospital data 
also allowed comparisons between socioeconomic 
groups.
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emotional, social and material QoL.4–7 More than a third 
of women with HMB report severe pain.7 HMB is also 
associated with morbidity, including anaemia and related 
fatigue.8 9 Women with HMB experience reduced partici-
pation in social activities and their personal relationships 
and attendance at work can be adversely affected.10
In order to improve the QoL of women with HMB, 
it is important to understand both the aetiology of 
this condition and its management in primary and 
secondary care.11 The prevalence of HMB and condi-
tions which affect symptom severity has been reported 
to vary by ethnicity.12–15 In addition, cultural norms and 
patient choice for treatment may vary between different 
groups.16 17
In this study, we used data from the National HMB 
Audit to examine symptom severity, QoL and symptom 
duration at women’s first gynaecology outpatient visit 
for HMB. The National HMB Audit was a 4-year project 
(2010–2014) that assessed patient-reported outcomes 
and experiences of care for women with HMB in England 
and Wales. Our objective is to examine symptom severity 
and duration at the time of referral to secondary care by 
age, ethnicity and socioeconomic deprivation to get a 
better understanding of the burden of disease at the start 
of treatment in secondary care.
MeThODS
Data collection
Full details of the methods used in the National HMB 
Audit have been reported elsewhere.1 4 18 19 Women aged 
between 18 and 60 years in England and Wales who had a 
new referral for HMB to a gynaecology outpatient depart-
ment were eligible to participate in the National HMB 
Audit. Women who had visited a gynaecology outpa-
tient clinic for HMB within the previous 12 months were 
excluded. Recruitment took place between 1 February 
2011 and 31 January 2012.1 19
Women who consented to participate completed a base-
line questionnaire (58 questions) on age, ethnicity, dura-
tion of HMB symptoms, obstetric history, prior treatment 
received for HMB and comorbidities. The questionnaire 
also collected patient-reported HMB-specific and generic 
QoL measures.
Scores for symptom severity and condition-specific 
health-related quality of life (HRQoL) were adapted from 
the Uterine Fibroid Symptom and Quality of Life (UFS-
QoL) questionnaire.20 Of five candidate questionnaires 
evaluated, only the UFS-QoL could be used throughout 
the care pathway, measured HRQoL and was psychomet-
rically strong.18 The UFS-QoL was therefore adapted for 
HMB and a UK population. We conducted semi-struc-
tured interviews with women (n=7) and clinicians (n=5) 
and a mini focus group (n=3) with local HMB Audit 
coordinators to determine suitable alternative words to 
describe HMB, and to identify words not clearly under-
stood in UK English. Based on this, we changed the 
wording to refer to ‘heavy menstrual bleeding’ (ie, heavy 
periods) rather than ‘fibroids’, changed ‘checking’ to 
‘ticking’; ‘soiling’ to ‘staining’; ‘blue’ to ‘low’; and ‘wiped 
out’ to ‘exhausted’. The adapted version performed 
acceptably in a psychometric evaluation. Overall, the 
symptom severity subscale and the HRQoL subscale 
of the UFS-QoL used as outcomes demonstrated the 
strongest psychometric properties and have been used 
to report the audit data. The UFS-QoL consists of eight 
symptom items and 29 HRQoL items. The symptom 
items are scored to produce a severity subscale and the 
HRQoL items are scored into subscales (concern, activi-
ties, energy/mood, control, self-consciousness and sexual 
function). The HRQoL subscales can be used separately 
or combined into an overall HRQoL score. We use the 
overall HRQoL score in this paper.
A generic HRQoL measure was derived from the 
European Quality of Life-5 Dimensions (EuroQol-5 
or EQ-5D).21 This generic measure was used because 
it is the instrument recommended by the Department 
of Health and allows comparisons with other national 
studies, such as the Patient Reported Outcome Measures 
study of common elective surgical procedures.21 Women 
completed the questionnaire in hospital before their 
consultation. Using multiple sources of data, the recruit-
ment rate of the audit was estimated to be 31.9%.1 
Descriptive results from the National HMB Audit have 
been published elsewhere.1 4 18 19
Data from the prospective audit were linked at patient 
level to records from Hospital Episode Statistics (HES) 
and Patient Episode Database for Wales (PEDW), admin-
istrative databases that capture all inpatient and outpa-
tient episodes in English and Welsh NHS hospitals. 
Data linkage was performed using deterministic linkage 
criteria that included NHS number, sex and date of birth.
Measures
Symptom severity, condition-specific QoL and generic 
QoL scores and the reported duration of symptoms at the 
first outpatient visit were used as outcomes in this study. 
The severity and QoL scores were analysed as contin-
uous variables. Symptom severity scores ranged from 0 
(best possible score) to 100 (greatest symptom severity, 
worst possible score). Condition-specific QoL ranged 
from 0 (poorest QoL) to 100 (best QoL). Generic QoL 
is expressed on a scale with 0 representing death and 1 
perfect health.22 Women were asked, ‘How long have 
you had symptoms of heavy menstrual bleeding’, with 
‘2 months or less’, ‘more than 2 months but less than 
1 year’, ‘more than 1 year’ and ‘don’t know’ as possible 
response categories. For analysis, duration of symptoms 
was grouped as ‘<1 year’, ‘≥1 year’ with ‘don’t know’ 
coded as missing. Levels of missing data on HMB symp-
toms and HRQoL were low (2.2% for severity, 4.8% for 
condition-specific QoL and 9.9% for generic QoL, and 
3.0% for symptom duration).
Age was categorised as 18–34, 35–39, 40–44, 45–49 and 
≥50 years for analysis. Women reported their ethnicity as 
‘white’, ‘mixed’, ‘Asian or Asian British’, ‘black or black 
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British’, ‘Chinese’ or ‘other’. For analysis, the ‘mixed’, 
‘Chinese’ and ‘other’ groups were combined as ‘other’ 
due to small numbers of women reporting these ethnic-
ities. Self-reported height and weight data were used to 
derive body mass index (BMI), categorised according to 
WHO groups as ≤25, 25–30 and ≥30.23 Women reported 
how many times they had seen their general practitioner 
(GP) for HMB in the year prior to their first outpatient 
visit, and this was grouped as 0, 1–2, 3–4, >4 for analysis 
(‘don’t know’ was coded as missing).
Women reported their parity, grouped for analysis 
as ‘nulliparous’ or ‘parous’. Women were also asked, 
‘Have you been told by a doctor that you have any of the 
following: heart disease (for example angina, heart attack 
or heart failure), high blood pressure, lung disease (for 
example chronic bronchitis or emphysema), diabetes, 
depression, thyroid disorder, kidney disease, cancer 
(within the last 5 years).’ For analysis, the number of 
comorbidities reported was grouped as 0, 1, ≥2.
Information on socioeconomic deprivation (Index of 
Multiple Deprivation (IMD)) was extracted from HES and 
PEDW. IMD is a relative measure of deprivation for small 
areas across a number of domains, including income, 
employment, education and housing. We used quintiles of 
IMD (level 1=most deprived areas, level 5=least deprived 
areas). The methods used to calculate IMD scores in each 
country in the UK are similar but not directly compa-
rable.24 For analysis, we generated a combined measure 
of deprivation for England and Wales by assigning those 
in each country-specific quintile to the same quintile in 
a combined measure. This preserved women’s relative 
deprivation position within each country.
Statistical analysis
Means and SDs and proportions were used to describe 
the cohort. Regression analyses were used to examine the 
relationship between age, ethnicity and socioeconomic 
deprivation and each of the outcomes. For the scores 
representing symptom severity, condition-specific QoL 
and generic QoL, multivariable linear regression was 
used to calculate adjusted differences in mean scores. For 
duration of symptoms (<1 year and ≥1 year), multivariable 
logistic regression was used to calculate adjusted ORs. 
Regression models included BMI, parity and number of 
comorbidities as potential confounders. Levels of missing 
data were low (<3%) for the majority of variables with the 
exception of ethnicity (7% missing) and BMI (approxi-
mately 23% missing, table 1). Missing values for explan-
atory variables were imputed using multiple imputation 
by chained equations25 and statistical coefficients were 
obtained using 10 imputed data sets and combined using 
Rubin’s rules.26
eThICAl APPROvAl
The data are from the National Heavy Menstrual Bleeding 
(HMB) Audit. Based on the Health Research Authority’s 
guidance, audits are regulated as standard clinical prac-
tice outside of the Research Ethics Service.27
ReSulTS
Patient characteristics
Fifteen thousand three hundred and twenty-five eligible 
women completed the questionnaire at their first visit to 
Table 1 Patient characteristics at the first gynaecology 
outpatient visit for HMB (% and number unless otherwise 
stated)
Full cohort
(n=15 325)
Age, mean (SD) in years 42.3 (7.6)
Age groups
  18–34 14.9 (2283)
  35–39 12.9 (1971)
  40–44 26.6 (4071)
  45–49 31.3 (4794)
  ≥50 14.4 (2206)
Body mass index, mean (SD) in kg/m2 27.3 (5.4)
Body mass index, categories
  ≤25 39.6 (4681)
  25–30 31.7 (3739)
  ≥30 28.7 (3392)
  Missing 3513
Parity
  Nulliparous 17.0 (2530)
  Parous 83.0 (12 338)
  Missing 457
Number of reported comorbidities
  0 66.3 (10 165)
  1 25.3 (3878)
  ≥2 8.4 (1282)
Ethnicity
  White 88.3 (12 614)
  Asian or Asian British 4.3 (607)
  Black or black British 5.4 (770)
  Other 2.0 (292)
  Missing 1042
Socioeconomic deprivation (IMD)
  Quintile 1 (most deprived) 23.5 (3418)
  Quintile 2 21.7 (3159)
  Quintile 3 20.2 (2944)
  Quintile 4 18.7 (2720)
  Quintile 5 (least deprived) 15.8 (2304)
  Missing 780
HMB, heavy menstrual bleeding; IMD, Index of Multiple 
Deprivation.
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a gynaecology outpatient department and 15 294 (99.8%) 
could be linked to HES or PEDW which provided infor-
mation on socioeconomic deprivation. The women’s 
mean age was 42.3 years (SD 7.6) and BMI was 27.3 (SD 
5.4) (table 1). About one in five were nulliparous and 
one in three reported at least one comorbidity. 11.7% 
of women reported a minority ethnic background, with 
black or black British (5.4%) and Asian or Asian British 
(4.3%) being the largest minority ethnic groups. Women 
in the two least socioeconomically deprived national quin-
tile groups (18.7% in quintile 4 and 15.8% in quintile 5) 
were under-represented given that, per definition, 20% 
of women are expected to be in each group. The distri-
bution of symptom severity, condition-specific QoL and 
generic QoL, and symptom duration by level of depriva-
tion did not vary significantly between women in England 
and Wales (data not shown).
The mean score for symptom severity was 61.8 (SE 0.17) 
with 74.0% of women reporting that they had HMB symp-
toms for more than 1 year. The mean score for condi-
tion-specific QoL was 34.7 (SE: 0.18) and for generic QoL 
was 0.65 (SE: 0.28) (table 2).
Severity of symptoms and Qol by socioeconomic deprivation
Symptom severity scores gradually increased with 
increasing socioeconomic deprivation (table 2). Condi-
tion-specific and generic QoL scores also showed a wors-
ening gradient according to deprivation. In other words, 
women living in more deprived areas reported more 
severe symptoms (difference −6.1; 95% CI −7.2 to −4.9, 
between least and most deprived quintiles) and a poorer 
QoL (difference 6.3; 95% CI 5.1 to 7.5) at their first 
gynaecology outpatient visit for HMB than those living in 
less deprived areas.
Severity of symptoms and Qol by age and ethnicity
Symptom severity showed a gradual decrease with 
increasing age, indicating that older women reported less 
severe symptoms at their first outpatient visit for HMB 
(difference −5.9; 95% CI −7.2 to −4.6 between oldest 
and youngest age groups, table 2). QoL scores based on 
both the condition-specific and the generic measures 
increased with increasing age, which shows that older 
women reported better QoL at their first HMB outpatient 
visit (difference 7.3; 95% CI 5.9 to 8.7 between oldest and 
youngest age groups). Symptom severity also varied by 
ethnicity: black and Asian women reported less severe 
symptoms than white women (difference compared with 
white women −1.9 and −2.4, respectively, table 2). Condi-
tion-specific QoL did not vary significantly by ethnicity, 
whereas compared with white women, Asian women 
reported lower generic QoL scores (table 2).
Duration of symptoms
Women living in the most deprived areas were slightly less 
likely to report having had HMB symptoms for ≥1 year 
than those living in the less deprived areas. Women aged 
between 35 and 49 years were more likely to report having 
experienced HMB symptoms for ≥1 year than those 
younger than 35. Compared with white women, black 
women were more likely than white women to report 
symptoms for ≥1 year and Asian women were less likely.
DISCuSSIOn
Main findings
Women living in more socioeconomically deprived areas 
reported more severe HMB symptoms and poorer QoL 
at their first gynaecology outpatient visit. Older women 
reported less severe symptoms and better QoL than 
younger women. Reported symptom severity also varied 
by ethnicity with black and Asian women reporting 
less severe symptoms than women from white ethnic 
backgrounds.
Three quarters of the women referred to secondary care 
reported that they had had symptoms of HMB for at least 
1 year and women living in the most deprived areas were 
least likely to report having had HMB symptoms for ≥1 year.
Interpretation
More severe symptoms and poorer QoL at first outpatient 
visit by socioeconomic deprivation, after adjustment for 
possible differences in age, ethnicity and BMI, reflect that 
women from more deprived backgrounds report more 
severe problems at the start of treatment in secondary care 
but they were least likely to report that they had symptoms 
for at least 1 year. The difference in the symptom severity 
score between women from the least and the most deprived 
areas of about 6 is likely to be clinically significant, given 
that a difference of 5 points or more has been specified as 
clinically important in clinical trials.28 There is evidence 
that people from more socioeconomically deprived back-
grounds may be more accepting of symptoms, chronic pain 
or poorer HRQoL,29 which is a possible explanation for 
these findings. Conversely, those from more affluent socio-
economic backgrounds have been found to report greater 
impact of health conditions on their QoL, which may be 
linked to their higher expectations about health and life in 
general.30
Alternative explanations are that differences in 
symptom severity, QoL and symptom reflect inequitable 
access as well as differences in the nature and causes of 
HMB. Age is often found to be associated with symptom 
severity.31 32 Black women are two to three times more 
likely to have fibroids and endometriosis.32 Accepting 
heavy periods as normal may vary by ethnicity and other 
social factors, which in turn can also lead to reluctance to 
seek care for HMB.16 Ethnographic research suggests that 
some women of South Asian ethnicity do not seek health-
care for HMB due to the belief that heavy periods cleanse 
the body.17 We adjust for patient-level characteristics that 
may capture some of these differences but were unable to 
adjust for other unmeasured potential confounders.
The observation that women living in the most socioeco-
nomically deprived areas reported the most severe symp-
toms but were least likely to report having had symptoms 
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for ≥1 year may reflect the wording of the question; 
women were asked, ‘How long have you had symptoms of 
heavy menstrual bleeding?’ and women whose symptom 
severity had worsened may have reported the duration of 
the most recent severity, rather than the overall duration.
A key question is whether the observed differences 
in symptom severity and condition-specific QoL at the 
women’s first gynaecology outpatient visit are related 
to differences in women’s health-seeking behaviour or 
to differences in how GPs and gynaecologists decide on 
whether to refer a woman with HMB. A study of self-re-
ported healthcare-seeking behaviour in England did not 
find evidence that inequality in access to secondary care 
according to socioeconomic or ethnic backgrounds is 
related to patients being less likely to go to their GP or a 
hospital’s emergency department.33 Similarly, a survey of 
patients with chronic joint pain found that the propor-
tions of patients who said that they were seeking help 
from their GP did not differ according to their socioeco-
nomic background.34 On the other hand, a national study 
including 130 000 patients from more than 300 primary 
care practices in England found that older patients and 
those from more deprived areas were less likely to be 
referred to secondary care.35
Implications for policy and practice
In the UK, national guidelines for the management of 
HMB have been developed by the National Institute for 
Health and Care Excellence (NICE) and the Royal College 
of Obstetricians and Gynaecologists (RCOG).11 36 37 The 
National HMB Audit carried out a survey of NHS hospitals 
in England and Wales to find out how care for women with 
HMB is organised and delivered at local levels. It found 
that key systems such as the availability of local protocols, 
which specified local arrangements for patient referral and 
management in response to the NICE guidelines, were 
reported only by 30% of hospitals.38 Wide variation in the 
investigations and treatments that were offered to women 
with HMB in primary care were also noted. The implemen-
tation of locally agreed referral pathways, recommended by 
the RCOG, will help reduce this variation.39
Women with HMB in this study reported substantially 
worse QoL (EQ-5D mean: 0.65, SD: 0.33) than the popula-
tion average for women in England (mean: 0.85, SD: 0.003), 
and compared with women with incontinence (mean: 0.73, 
SD: 0.26).40 41 This reinforces the need for interventions 
to focus on improving women’s QoL, as recommended by 
recent NICE guidelines.11 Obesity can be associated with 
HMB so health promotion interventions around diet and 
exercise could supplement HMB-specific interventions. 
Criteria for what constitutes a meaningful improvement in 
QoL are less clear. Awareness raising activities relating to the 
availability of treatments for HMB could increase healthcare 
seeking before symptoms become severe. This may be partic-
ularly beneficial for those from more deprived backgrounds, 
who may be more accepting of chronic pain and worse QoL. 
In highlighting differences in symptom severity at their first 
gynaecology outpatient visit, our findings draw attention 
to the lack of an agreed threshold for referral of women 
with HMB to secondary care in terms of symptom severity 
and QoL. Routine measurement of both symptom severity 
and QoL may be required to stimulate greater consistency 
in referral thresholds but validated instruments specific to 
HMB are currently lacking. As there is no widely used condi-
tion-specific measure of condition-specific QoL for HMB, 
the National HMB Audit used the UFS-QoL questionnaire, 
adapted for a UK population of women with HMB.18
Strengths and limitations
This study is the first to examine the relationship between 
sociodemographic factors and patient-reported HMB 
symptom severity, QoL and symptom duration in an 
outpatient setting. It used data collected by a national 
audit carried out in England and Wales, which produced 
a relatively large sample. We estimated that the National 
HMB Audit recruited about 30% of all eligible women. 
There is no direct way to compare the characteristics 
of the women who were recruited and those who were 
not. However, the characteristics of the women who were 
recruited were broadly representative of the UK popula-
tion in terms of the distributions of ethnicity and age.42 43
Survey questionnaires were only available in the English 
language, so non-English speakers are likely to be under-rep-
resented. On the other hand, case ascertainment varied by 
provider and women from providers with higher case ascer-
tainment (ascertainment >45%) were more often from 
minority ethnic backgrounds and more deprived areas than 
those referred to providers with lower case ascertainment,4 
which suggests that the impact of not having questionnaires 
in other languages is likely to be small.
COnCluSIOn
About three in four women at their first visit to a gynaeco-
logical outpatient clinic for HMB in England and Wales 
reported that they had symptoms at least 1 year before 
they were referred to secondary care. Women from more 
deprived areas reported more severe HMB symptoms and 
a poorer QoL, which demonstrates a higher burden of 
disease at the time of referral to secondary care. Primary 
and secondary care providers should examine to what 
extent these differences reflect barriers in access to gynae-
cological secondary care services or women’s perceptions of 
their menstrual problems and health-seeking behaviour.
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